UCB U.S. News

25 Rare Disease Day: Seeing People in Need

This Rare Disease Day, we’re continuing to raise awareness about seeing people in need and our commitment to innovating and finding solutions for patients living with rare diseases.

Read More Share:

Feb

25 UCB - Sustaining Growth, Now and Into the Future

Read More Share:

Feb

23 UCB and Microsoft Expand Collaboration to Accelerate Drug Discovery and Development

Read More Share:

Feb

05 The Lancet Publishes Two Phase 3 Studies Detailing Bimekizumab Data in Moderate to Severe Plaque Psoriasis

Read More Share:

Feb

03 UCB Community Health Fund Supports Seven U.S. Organizations on COVID-19 Support Projects

Today, UCB announced seven U.S-based organizations received support from the UCB Community Health Fund managed by the King Baudouin Foundation in Belgium.

Read More Share:

Categories

Archives

Feb

25

Rare Disease Day: Seeing People in Need

Feb

25

UCB - Sustaining Growth, Now and Into the Future

Feb

23

UCB and Microsoft Expand Collaboration to Accelerate Drug Discovery and Development

Feb

05

The Lancet Publishes Two Phase 3 Studies Detailing Bimekizumab Data in Moderate to Severe Plaque Psoriasis

Feb

03

UCB Community Health Fund Supports Seven U.S. Organizations on COVID-19 Support Projects

Choose Country

UCB in the U.S.

Innovation

Disease Areas

Sustainability

Newsroom

Contact

Categories

Archives

Feb

25

Rare Disease Day: Seeing People in Need

Feb

25

UCB - Sustaining Growth, Now and Into the Future

Feb

23

UCB and Microsoft Expand Collaboration to Accelerate Drug Discovery and Development

Feb

05

The Lancet Publishes Two Phase 3 Studies Detailing Bimekizumab Data in Moderate to Severe Plaque Psoriasis

Feb

03

UCB Community Health Fund Supports Seven U.S. Organizations on COVID-19 Support Projects

Choose Country

UCB in the U.S.

Innovation

Disease Areas

UCB Worldwide

Sustainability

Newsroom

Contact